Citadel Advisors’s Turmeric Acquisition Corp. Class A Ordinary Shares TMPM Stock Holding History

Citadel Advisors’s Portfolio TMPM Stock Details TMPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-472,826	Closed	-$4.73M	–	16032
2022 Q3	$4.73M	Sell	472,826 -3,936	-0.8%	-$39.2K	﹤0.01%	3968
2022 Q2	$4.72M	Sell	476,762 -240	-0.1%	-$2.37K	﹤0.01%	3905
2022 Q1	$4.69M	Sell	477,002 -219	-0%	-$2.15K	﹤0.01%	4292
2021 Q4	$4.68M	Sell	477,221 -3,465	-0.7%	-$33.9K	﹤0.01%	4420
2021 Q3	$4.71M	Buy	480,686 +451,816	+1,565%	+$4.41M	﹤0.01%	4418
2021 Q2	$286K	Buy	28,870 +3,909	+16%	+$38.5K	﹤0.01%	11387
2021 Q1	$244K	Buy	+24,961	New	+$254K	﹤0.01%	11298

Citadel Advisors's TMPM Position: Q4 2022 in Review

Citadel Advisors sold out of Turmeric Acquisition Corp. Class A Ordinary Shares (TMPM) in Q4 2022, closing a stake of 472,826 shares — an estimated $4.73M sold.

Citadel Advisors first reported a position in TMPM in Q1 2021 and held it in 7 quarters. The position peaked at $4.73M in Q3 2022. 0 funds tracked by Wall St. Rank hold TMPM as of Q4 2022.

Citadel Advisors reported no remaining Turmeric Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 472,826 Turmeric Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $4.73M.
Citadel Advisors first reported a position in Turmeric Acquisition Corp. Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Citadel Advisors's Turmeric Acquisition Corp. Class A Ordinary Shares position peaked at $4.73M in Q3 2022.
0 funds tracked by Wall St. Rank held Turmeric Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.